Heart rate

Jazzercise, Inc. Announces First-Ever Interface Migration for Jazzercise On Demand App

Wednesday, October 27, 2021 - 5:00pm

announced an interface migration for their app and web-based offering, Jazzercise On Demand .

Key Points: 
  • announced an interface migration for their app and web-based offering, Jazzercise On Demand .
  • This is the first interface migration for Jazzercise On Demand since the app launched in 2019.
  • This new interface will also allow users to use their Apple Watches as a convenient remote for the On Demand app.
  • Jazzercise On Demand subscribers can also look forward to new programs and challenges within the app following the interface migration.

Wearable Medical Devices Ascendant Regardless of COVID-19

Wednesday, October 27, 2021 - 1:00pm

With ongoing developments in areas such as Internet of things (IoT) and Artificial Intelligence (AI), and given the backdrop of the COVID-19 pandemic, the demand for mobile or wearable medical devices is, understandably, on the rise.

Key Points: 
  • With ongoing developments in areas such as Internet of things (IoT) and Artificial Intelligence (AI), and given the backdrop of the COVID-19 pandemic, the demand for mobile or wearable medical devices is, understandably, on the rise.
  • This category encompasses wearable therapeutic devices, wearable monitoring and diagnostic devices, and health and fitness devices.
  • According to the report's summary, demand for wearable medical devices is expected to be driven by a "high prevalence of chronic diseases," and an "increasing geriatric population."
  • So while future research might indicate more clearly the impact of COVID-19 on the market, it is clear that demand for wearable medical devices is well established and growing regardless.

Smart Eye Acquires iMotions to Unlock Potential for Multi-Modal, Human Behavioral Research

Tuesday, October 26, 2021 - 6:18pm
Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20211026006007/en/
    iMotions joins Smart Eye (Photo: Business Wire)
    As the global leader in Human Insight AI, Smart Eye will couple its advanced eye tracking and emotion AI technologies with iMotions innovative, multiple-sensor data collection and analytics software to create the first powerhouse in human behavioral research and analysis.
  • Integrating iMotions Behavioral Research Suite will expand multi-modal data and synchronized analytics, helping to accelerate Smart Eyes leadership in the rapidly emerging field of Human Insight AI in automotive but also in new markets.
  • Smart Eye and iMotions have shared visions for eye tracking and multi-modal research for many years, said Peter Hartzbech, Founder and CEO of iMotions.
  • Smart Eye is the global leader in Human Insight AI, technology that understands, supports and predicts human behavior in complex environments.

Supernatural Announces Supernatural Boxing: A Full Body Fitness Experience For Home And Beyond

Tuesday, October 26, 2021 - 3:00pm

LOS ANGELES, Oct. 26, 2021 /PRNewswire/ -- Supernatural, the leading virtual reality fitness experience today announced Supernatural Boxing, an entirely new full-body cardio workout joining the company's platform of immersive fitness and wellness experiences built for Oculus Quest and Oculus Quest 2. Supernatural Boxing is designed to achieve explosive aerobic-capacity while torching the core and sharpening the mind, alongside Supernatural's original, full-body cardio workout, Supernatural Flow, as well as its Guided Meditation and coach-led Stretch sessions. Boxing workouts are immediately available on the Supernatural app in the Oculus App Store.

Key Points: 
  • The addition of Supernatural Boxing invites members to "go the distance" offering new goals and challenges for mind and body and an entirely fresh perspective on fitness.
  • "Supernatural Boxing is an incredible workout that recruits new muscle groups and focuses the mind," said co-founder and CEO Chris Milk.
  • Supernatural Boxing will be led by Supernatural's dynamic roster of expert coaches and overseen by Head of Fitness and Muay Thai athlete, Coach Leanne Pedante.
  • Expert coaching: Supernatural Boxing creates an intimate, one on one, trainer-athlete dynamic unmatched by any other at-home digital fitness product.

ŌURA Health Launches Oura Ring Generation 3

Tuesday, October 26, 2021 - 2:00pm

URA Health , the wearable health platform that delivers accurate, personalized health data, insights, and daily guidance, today announced the launch of the Oura Ring Generation 3.

Key Points: 
  • URA Health , the wearable health platform that delivers accurate, personalized health data, insights, and daily guidance, today announced the launch of the Oura Ring Generation 3.
  • The Oura Ring Gen3s advancements in period prediction represent just the beginning of Ouras steadfast and long-term investment in the areas of womens health, reproductive health, and family planning.
  • All new Oura Ring members will receive 6 free months of membership and any existing Oura Ring member who upgrades to the new Oura Ring Gen3 will receive a discount on their new ring and a free lifetime Oura membership.
  • URA Health is the company behind the health tech wearable that provides actionable insights on sleep and its impact on overall health.

Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19

Tuesday, October 26, 2021 - 1:15pm

Phase 3 clinical trial to incorporate viral load testing for a minimum of 300 patients.

Key Points: 
  • Phase 3 clinical trial to incorporate viral load testing for a minimum of 300 patients.
  • Engaged 46 clinical sites to date to complete the Phase 3 clinical trial.
  • Finalizing global manufacturing capabilities to support the production of at least 5 billion Bucillamine tablets for global commercialization in 2022.
  • With its acquisition of Psilocin Pharma Corp., Revive is advancing the development of Psilocybin-based therapeutics in various diseases and disorders.

Nutrition Tips Ahead of Halloween, According to Nicole Avena, Ph.D.

Monday, October 25, 2021 - 5:31pm

Nicole Avena, Ph.D. shares healthy habits to incorporate in between Halloween candy this season.

Key Points: 
  • Nicole Avena, Ph.D. shares healthy habits to incorporate in between Halloween candy this season.
  • Nicole Avena provides healthful tips this season:
    Sweet Potatoes Arent Just for Thanksgiving.
  • Instead of reaching for that Halloween candy when you want something sweet, try roasting some sweet potato with cinnamon.
  • By keeping ourselves active and finding those fun fall activities, we can stress less ahead of the holidays, adds Avena.

Aquestive Therapeutics Reports Positive Topline Data from Phase 1 Pharmacokinetic Trial of AQST-109 (epinephrine prodrug sublingual film) Supporting its Development as an Oral Alternative to Epinephrine Autoinjectors for the Emergency Treatment of Allergi

Monday, October 25, 2021 - 1:31pm

Based on the study results, Aquestive plans on continuing development of the target formulation to take forward into a pivotal PK study.

Key Points: 
  • Based on the study results, Aquestive plans on continuing development of the target formulation to take forward into a pivotal PK study.
  • All treatment-emergent adverse events (TEAEs) deemed at least possibly related were mild to moderate in nature across cohorts.
  • The changes observed suggest a comparable effect for AQST-109 when compared to autoinjectors in healthy volunteers.
  • Aquestive Therapeutics is developing a sublingual (SL) film containing a prodrug of epinephrine as an alternative dosage form to epinephrine injection (1 mg/mL).

Windtree Announces Notice of Allowance from the US Patent and Trademark Office for a New Istaroxime Patent

Monday, October 25, 2021 - 12:30pm

A notice of allowance is issued by the USPTO to indicate that the application has passed examination.

Key Points: 
  • A notice of allowance is issued by the USPTO to indicate that the application has passed examination.
  • The claims cover longer infusion durations of istaroxime for improved outcomes in treatment of acute heart failure.
  • Istaroxime is an investigational drug candidate being studied in acute heart failure and also in early cardiogenic shock.
  • The istaroxime patent estate is a priority for Windtree and we plan to add additional elements to it as data is obtained in our clinical studies.

Ketamine One Features Biostrap as Part of Inaugural Research Studies

Wednesday, October 20, 2021 - 8:00am

Upon completion of the Research Studies, Ketamine One will have the opportunity to implement a proprietary interactive dashboard and data management tool.

Key Points: 
  • Upon completion of the Research Studies, Ketamine One will have the opportunity to implement a proprietary interactive dashboard and data management tool.
  • We are excited to conduct the Research Studies and I would like to thank Biostrap for their involvement and support thus far.
  • With its Biostrap Labs research division, Biostrap offers wellness companies the opportunity to validate the efficacy of their products and services in a real-world setting.
  • As a collective enterprise, Ketamine One is dedicated to helping solve the growing need for safe and accessible mental health therapy.